143 related articles for article (PubMed ID: 19954714)
1. Population pharmacokinetics of lamotrigine in patients with epilepsy.
Milovanovic JR; Jankovic SM
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):752-60. PubMed ID: 19954714
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
Jankovic SM; Jovanovic D; Milovanovic JR
Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis.
Milovanovic JR; Jankovic SM
Int J Clin Pharmacol Ther; 2011 Jul; 49(7):428-36. PubMed ID: 21726493
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data.
Hussein Z; Posner J
Br J Clin Pharmacol; 1997 May; 43(5):457-65. PubMed ID: 9159559
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing valproate pharmacokinetics in children and adults.
Jankovic SM; Milovanovic JR; Jankovic S
Int J Clin Pharmacol Ther; 2010 Nov; 48(11):767-75. PubMed ID: 20979937
[TBL] [Abstract][Full Text] [Related]
6. [Population pharmacokinetics of lamotrigine in Chinese children with epilepsy].
Zhang S; Wang L; Lu W
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):105-9. PubMed ID: 18433522
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of lamotrigine in Chinese children with epilepsy.
He DK; Wang L; Qin J; Zhang S; Lu W; Li L; Zhang JM; Bao WQ; Song XQ; Liu HT
Acta Pharmacol Sin; 2012 Nov; 33(11):1417-23. PubMed ID: 23103620
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of lamotrigine in Indian epileptic patients.
Mallaysamy S; Johnson MG; Rao PG; Rajakannan T; Bathala L; Arumugam K; van Hasselt JG; Ramakrishna D
Eur J Clin Pharmacol; 2013 Jan; 69(1):43-52. PubMed ID: 22660444
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.
Rivas N; Buelga DS; Elger CE; Santos-Borbujo J; Otero MJ; Domínguez-Gil A; García MJ
Ther Drug Monit; 2008 Aug; 30(4):483-9. PubMed ID: 18641550
[TBL] [Abstract][Full Text] [Related]
10. Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics.
Brzaković BB; Vezmar Kovačević SD; Vučićević KM; Miljković BR; Martinović ZJ; Pokrajac MV; Prostran MŠ
J Clin Pharm Ther; 2012 Dec; 37(6):693-7. PubMed ID: 22583007
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.
Grasela TH; Fiedler-Kelly J; Cox E; Womble GP; Risner ME; Chen C
J Clin Pharmacol; 1999 Apr; 39(4):373-84. PubMed ID: 10197296
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of lamotrigine.
Chan V; Morris RG; Ilett KF; Tett SE
Ther Drug Monit; 2001 Dec; 23(6):630-5. PubMed ID: 11802095
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
Jankovic SM; Milovanovic JR
Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy.
Zhang ZB; Ji SM; Han Y; Zang LL; Wang YH; Lu W; Wang L; Wu Y
Eur J Clin Pharmacol; 2017 Apr; 73(4):445-453. PubMed ID: 28064355
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral contraceptives on lamotrigine levels depends on comedication.
Wegner I; Wilhelm AJ; Lambrechts DA; Sander JW; Lindhout D
Acta Neurol Scand; 2014 Jun; 129(6):393-8. PubMed ID: 24571554
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of tacrolimus in kidney transplant patients.
Velickovic-Radovanovic R; Catic-Djordjevic A; Milovanovic JR; Djordjevic V; Paunovic G; Jankovic SM
Int J Clin Pharmacol Ther; 2010 Jun; 48(6):375-82. PubMed ID: 20497746
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics Modeling of Lamotrigine in Jordanian Epileptic Patients Using Dried Blood Spot Sampling.
Dodin YI; Suyagh MF; Saleh MI; Nuseir ZT; Aburuz SM; Al-Qudah AA; Masri AT; Younes AM; Al-Ghazawi MA
Drug Res (Stuttg); 2021 Oct; 71(8):429-437. PubMed ID: 34255318
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.
Milosheska D; Lorber B; Vovk T; Kastelic M; Dolžan V; Grabnar I
Br J Clin Pharmacol; 2016 Aug; 82(2):399-411. PubMed ID: 27096250
[TBL] [Abstract][Full Text] [Related]
19. Dosing Recommendations Based on Population Pharmacokinetics of Lamotrigine in Mexican Adult Patients With Epilepsy.
Chávez-Castillo CE; Medellín-Garibay SE; Milán-Segovia RDC; Rodríguez-Leyva I; Romano-Moreno S
J Pharm Sci; 2020 Sep; 109(9):2902-2908. PubMed ID: 32534880
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy.
Jawad S; Yuen WC; Peck AW; Hamilton MJ; Oxley JR; Richens A
Epilepsy Res; 1987 May; 1(3):194-201. PubMed ID: 3504397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
